0001538762-23-000003.txt : 20230309 0001538762-23-000003.hdr.sgml : 20230309 20230309082230 ACCESSION NUMBER: 0001538762-23-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230309 DATE AS OF CHANGE: 20230309 EFFECTIVENESS DATE: 20230309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Io Therapeutics, Inc. CENTRAL INDEX KEY: 0001538762 IRS NUMBER: 274285636 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-475300 FILM NUMBER: 23718272 BUSINESS ADDRESS: STREET 1: 1805 E. GARRY AVENUE, SUITE 110 CITY: SANTA ANA STATE: CA ZIP: 92705-5851 BUSINESS PHONE: 650-219-5973 MAIL ADDRESS: STREET 1: 1805 E. GARRY AVENUE, SUITE 110 CITY: SANTA ANA STATE: CA ZIP: 92705-5851 D 1 primary_doc.xml X0708 D LIVE 0001538762 Io Therapeutics, Inc. 9450 PINECROFT DR., SUITE 9497 SPRING TX TEXAS 77387 832-260-6201 CALIFORNIA None None Corporation true Martin Sanders 9450 PINECROFT DR., SUITE 9497 SPRING TX TEXAS 77387 Executive Officer Vidyasagar Vuligonda 9450 PINECROFT DR., SUITE 9497 SPRING TX TEXAS 77387 Executive Officer Sharon Lew 9450 PINECROFT DR., SUITE 9497 SPRING TX TEXAS 77387 Executive Officer Sahani Chandraratna 9450 PINECROFT DR., SUITE 9497 SPRING TX TEXAS 77387 Director Biotechnology Decline to Disclose 06b false 2023-02-28 false true false 0 4158000 4158000 0 false 19 0 0 0 false Io Therapeutics, Inc. Martin E. Sanders Martin Sanders Chief Executive Officer 2023-03-01